Skip to main content

Table 4 Predicted target of metformin via PharmMapper and its docking value with different targets

From: Multiple therapeutic effect of endothelial progenitor cell regulated by drugs in diabetes and diabetes related disorder

Metformin
S. no. Protein name EST. free energy of binding (kcal/mol) EST. inhibition constant, Ki (mM) vdW+ Hbond+ desolv energy (kcal/mol) Electrostatic energy (kcal/mol) Total intermol. energy (kcal/mol) Frequency (%) Interact. surface
1. Beta secretase −5.54 0.086 −2.56 −2.98 −5.54 80 346.622
2. HSP 90 −4.09 1.01 −3.58 −0.50 −4.09 30 365.345
3. Fructose-1,6-bisphosphatase −2.93 7.15 −1.54 −1.39 −2.93 20 219.69
4. Neuraminidase +0.03 +0.00 +0.03 +0.03 30 17,111.543
5. CDK 2 −3.28 3.97 −1.42 −1.86 −3.28 100 269.215
6. Glutathione S transferase −0.03 944.98 +0.00 −0.03 −0.03 40 10,475.752
7 eNOS −6.8 0.01 −3.68 −3.13 −6.82 100 419.151